Original Research

Published on 19 Jun 2024

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia

in Psychopharmacology

Júlio César Menezes Vieira
Edna Afonso Reis
Augusto Afonso Guerra
Helian Nunes de Oliveira
Cristina Mariano Ruas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421501

1,386 views

Original Research

Published on 18 Jun 2024

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

in Psychopharmacology

Tigran Makunts
Ruben Abagyan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1414622

1,259 views

Original Research

Published on 11 Jun 2024

Nicotine and fluoxetine alter adolescent dopamine-mediated behaviors via 5-HT1A receptor activation

in Psychopharmacology

Menglu Yuan
Frances M. Leslie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1380123

1,252 views

Editorial

Published on 10 Jun 2024

Editorial: Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

in Psychopharmacology

Leehe Peled-Avron
Jacob S. Aday
Amilia Lydia Kalafateli
Holly K. Hamilton
Joshua D. Woolley

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1431389

1,360 views

Review

Published on 10 Jun 2024

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids

in Psychopharmacology

David J. Heal
Jane Gosden
Sharon L. Smith

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322434

1,818 views
1 citation

Methods

Published on 04 Jun 2024

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”

in Psychopharmacology

Julia Bornemann
James B. Close
Kirran Ahmad
Tommaso Barba
Kate Godfrey
Lauren Macdonald
David Erritzoe
David Nutt
Robin Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1320780

4,529 views

Editorial

Published on 27 May 2024

Editorial: Perspectives on new fast-acting antidepressants

in Psychopharmacology

Rodrigo Simonini Delfino
Balwinder Singh
Acioly L. T. Lacerda

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1430990

844 views

Original Research

Published on 21 May 2024

A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia

in Psychopharmacology

Claudia Carmassi
Valerio Dell’Oste
Sara Fantasia
Andrea Bordacchini
Carlo Antonio Bertelloni
Pietro Scarpellini
Virginia Pedrinelli

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1382013

1,306 views

Brief Research Report

Published on 10 May 2024

Hype or hope? Ketamine for the treatment of depression: results from the application of deep learning to Twitter posts from 2010 to 2023

in Psychopharmacology

Qin Xiang Ng
Yu Liang Lim
Clarence Ong
Silas New
Johnson Fam
Tau Ming Liew

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1369727

1,345 views

Editorial

Published on 06 May 2024

Editorial: Psychotropic overprescribing to youth: scope of the problem, causes, and possible solutions

in Psychopharmacology

Jennifer L. McLaren
Julie M. Zito
Jörg M. Fegert
Erin R. Barnett

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1418600

1,074 views

Case Report

Published on 29 Apr 2024

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

in Psychopharmacology

Florine M. Wiss
Samuel S. Allemann
Henriette E. Meyer zu Schwabedissen
Céline K. Stäuble
Thorsten Mikoteit
Markus L. Lampert

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1397876

1,753 views
1 citation

Case Report

Published on 26 Apr 2024

Case report: Escitalopram-associated lower limb edema

in Psychopharmacology

Mohamed Hassan Ahmed
Mena Al-Kubaisi
Safa Abdulmajeed Al-Rawi
Omar Hosam Salama
Hebah Mahmoud Abutayyem

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1394813

2,416 views

Perspective

Published on 18 Apr 2024

Psychiatric and legal considerations for ketamine treatment within prison settings

in Psychopharmacology

Michael Bayrhammer-Savel
Martin Ortner
Marie-Claire Van Hout
Arkadiusz Komorowski

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1316108

1,414 views
1 citation

Original Research

Published on 18 Apr 2024

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

in Psychopharmacology

Julia Ruixi Wang
Samuel J. Mendez Araque
Gina Micciche
Andrew McMillan
Emily Coughlin
Rosalie Mattiola
Diana English
Kristopher Kaliebe

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1301960

2,164 views

Original Research

Published on 10 Apr 2024

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees

in Psychopharmacology

Matthew X. Lowe
Hannes Kettner
Del R. P. Jolly
Robin L. Carhart-Harris
Heather Jackson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1279887

3,383 views
1 citation

Original Research

Published on 09 Apr 2024

Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retrospective cohort study

in Psychopharmacology

Katharina Wien
Julia Thern
Anika Neubert
Britta-Lena Matthiessen
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1304844

1,274 views

Navigation group

Articles

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

Nicotine and fluoxetine alter adolescent dopamine-mediated behaviors via 5-HT1A receptor activation

Editorial: Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”

Editorial: Perspectives on new fast-acting antidepressants

A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia

Hype or hope? Ketamine for the treatment of depression: results from the application of deep learning to Twitter posts from 2010 to 2023

Editorial: Psychotropic overprescribing to youth: scope of the problem, causes, and possible solutions

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Case report: Escitalopram-associated lower limb edema

Psychiatric and legal considerations for ketamine treatment within prison settings

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees

Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retrospective cohort study